Net Cash Provided by (Used in) Operating Activities |
381 K |
USD |
-32.9% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-30 K |
USD |
-100% |
Dec 31, 2023 |
Q4 2023 |
Net Cash Provided by (Used in) Investing Activities |
16 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
7.68 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
397 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
7.54 M |
USD |
-31% |
Mar 31, 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
27 M |
USD |
+0.42% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-101 K |
USD |
-131% |
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
121 K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
-9 K |
USD |
-102% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
943 K |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
4 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
236 K |
USD |
+168% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
306 K |
USD |
|
Dec 31, 2023 |
Q4 2023 |